(Q39913206)

15 September 2017

title

The role of emerging manufacturers in access to innovative vaccines of public health importance (English)

1 reference

15 September 2017

0 references

Julie B Milstien

1

1 reference

15 September 2017

Miloud Kaddar

series ordinal

2

1 reference

15 September 2017

language of work or name

English

0 references

publication date

29 December 2009

1 reference

15 September 2017

1 reference

15 September 2017

volume

28

1 reference

15 September 2017

issue

9

1 reference

15 September 2017

page(s)

2115-2121

1 reference

Emerging markets & emerging needs: developing countries vaccine manufacturers' perspective & its current status.

15 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.12.036

Reaching international GMP standards for vaccine production: challenges for developing countries

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.12.036

Access to vaccine technologies in developing countries: Brazil and India

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.12.036

The Brazilian vaccine manufacturers' perspective and its current status

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.12.036

China's growing biomedical industry

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.12.036

10.1016/J.VACCINE.2009.12.036

7 January 2021

Identifiers

DOI

1 reference

15 September 2017

1 reference